Picture of Hyenergy SA logo

HEN Hyenergy SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+2.96%
3m-16.7%
6m-12.61%
1yr-1.45%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital22.77%
Return on Equity35.67%
Operating Margin58.37%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Hyenergy SA EPS forecast chart

Profile Summary

Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
June 10th, 2010
Public Since
February 8th, 2011
No. of Employees
27
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
33,581,081

HEN Share Price Performance

Upcoming Events for HEN

Similar to HEN

Picture of Bioton SA logo

Bioton SA

pl flag iconWarsaw Stock Exchange

Picture of Braster SA logo

Braster SA

pl flag iconWarsaw Stock Exchange

Picture of Captor Therapeutics SA logo

Captor Therapeutics SA

pl flag iconWarsaw Stock Exchange

Picture of Genomed SA logo

Genomed SA

pl flag iconWarsaw Stock Exchange

Picture of Genomtec SA logo

Genomtec SA

pl flag iconWarsaw Stock Exchange

FAQ